UpdatesGeneral Updates
Aurobindo Pharma's subsidiary, AuroPeptides, completed a US FDA inspection with only one observation regarding facility maintenance.
Aurobindo Pharma LimitedAUROPHARMA · Filed with the exchange
This observation does not relate to data integrity or GMP compliance, and corrective action has been initiated, affirming robust quality standards.
No comments yet. Be the first.